Funding
The Epigenetic Etiology of Human Disease Lab at Mayo Clinic receives ongoing research support from several sources within the National Institutes of Health.
Grants
| Investigator & Role |
Grant Title |
Funding Source |
Duration |
| Keith D. Robertson, Ph.D., principal investigator |
Synthetic lethal targeting of SETD2 in renal cell carcinoma (R01 CA271503) |
National Cancer Institute |
2/2023 to 1/2028 |
| Keith D. Robertson, Ph.D., principal investigator |
RNA methylation as a novel effector of SETD2 in kidney cancer (R21 CA283539) |
National Cancer Institute |
4/2024 to 3/2026 |